Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Company Overview
Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
| Name: | Pharmacyclics Inc. |
|---|---|
| Address: | 995 East Arques Avenue Sunnyvale, California 94085-4521 |
| Phone: | (408) 774-0330 |
| Email: | NA |
| Web site: | www.pharmacyclics.com |
| CEO: | Robert W Duggan |
| % Owned By | Shares Bought In Last 90 Days | Shares Sold In Last 90 Days | |
| Insiders | NA | 45,531 | 45,531 |
| Institutional | 72.18% | NA | NA |
| Change in Short Interest as of 3/15/2013 | -7.94% | ||
| Short Interest as % of Float as of 3/15/2013 | 6.10% | ||
| Number of Employees | 150 |
|---|---|
| Revenue per Employee | $1,098,050 |
| Income per Employee | $79,907 |
| Market Capitalization (thousands) | $5,471,030 |
| Enterprise Value (thousands) | $5,468,495 |
| Auditors Opinion | Unqualified |
Officers and Directors
Robert W Duggan, Mahkam Zanganeh, Joshua T Brumm, Elizabeth Faust, David J Loury, Joseph J Buggy, Lori Anne Kunkel, James N Lowder, Gregory W Hemmi, Heow Tan, Scott T Shearer, Jesse McGreivy, Maria Fardis, Richard B Love, Dana Lee, Fong Wang Clow, Richard van den Broek, David Duane Smith, Minesh P Mehta, Robert F. G Booth, Eric H Halvorson, Kenneth A Clark, Paula S Boultbee, Michael Crum, Rainer M Erdtmann
